1. Academic Validation
  2. Bone Marrow-Derived Myofibroblasts Promote Gastric Cancer Metastasis by Activating TGF-β1 and IL-6/STAT3 Signalling Loop

Bone Marrow-Derived Myofibroblasts Promote Gastric Cancer Metastasis by Activating TGF-β1 and IL-6/STAT3 Signalling Loop

  • Onco Targets Ther. 2020 Oct 16;13:10567-10580. doi: 10.2147/OTT.S266506.
Jianzheng Wang  # 1 Qingli Li  # 1 Xiaojiao Cheng 1 Baiwen Zhang 1 Jiacheng Lin 1 Yao Tang 1 Fuli Li 1 Chung S Yang 2 Timothy C Wang 3 Shuiping Tu 1
Affiliations

Affiliations

  • 1 Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, People's Republic of China.
  • 2 Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
  • 3 Department of Medicine, College of Physicians & Surgeons, Columbia University, New York, NY 10032, USA.
  • # Contributed equally.
Abstract

Background: Murine bone marrow-derived myofibroblasts (BMFs) have previously been shown to promote gastric Cancer growth. However, whether BMFs promote gastric Cancer cell metastasis remains largely unknown.

Methods: Wound healing assay, Transwell invasion and migration assay and 3D organotypic co-culture systems were conducted to study the effects of BMFs on invasion and migration of gastric Cancer cells and the invasion and migration ability of gastric Cancer stem cell-like cells (CSC-LCs) induced by BMFs. We employed two animal model to study the role of BMFs on the in vivo metastasis of gastric Cancer cells and the metastatic ability of gastric BMF-induced CSC-LCs. A human gastric Cancer tissue microarray and TCGA gastric Cancer database were analysed to study the relationship between the expression of IL-6 and TGF-β1 and clinicopathological characteristics and survival in gastric Cancer.

Results: We found that BMFs promoted the in vitro migration and invasion of gastric Cancer cells. BMFs promoted liver, lung, subcutaneous, and splenic metastases of MKN28 cells in the spleen injection liver metastasis model and co-injection of caudal vein (IOCV) mouse model. BMFs reprogrammed non-gastric Cancer stem cell (CSC) to CSC-LCs and enhanced CSC-LC migration and metastasis. BMF-derived IL-6 and gastric Cancer cell-secreted TGF-β1 mediated the interaction between BMFs and gastric Cancer cells, promoting tumour metastasis. BMFs enhanced the expressions of STAT3 and p-STAT3 in co-cultured gastric Cancer cells. A combination of Napabucasin and Galunisertib exhibited the strongest inhibition of cell migration compared to when administered alone. Gastric Cancer tissue array and TCGA database indicated that the overexpression of IL-6 and TGF-β1 was associated with gastric Cancer metastasis.

Conclusion: Our results demonstrated that BMFs promote gastric Cancer metastasis through the activation of the TGF-β1 and IL-6/STAT3 signalling pathways. Targeting the inhibition of these interactions may be a potent therapeutic strategy for addressing gastric Cancer metastasis.

Keywords

IL-6; TGF-β1; bone marrow-derived myofibroblasts; gastric cancer; metastasis.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-13919
    98.85%, STAT3 Inhibitor